KUANO
Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
KUANO
Industry:
Artificial Intelligence Biotechnology
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.kuano.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit LocalBusiness Schema Squarespace
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Seed Round - Kuano
ACF Investors
ACF Investors investment in Seed Round - Kuano
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Kuano
Innovate UK
Innovate UK investment in Grant - Kuano
Official Site Inspections
http://www.kuano.ai
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Kuano"
About Us — Kuano
About Kuano Kuano is revolutionisingthe way drugs are designed and prioritised, accelerating life-saving discoveries, creating better outcomes and generating savings.See details»
Kuano - Crunchbase Company Profile & Funding
Kuano may be growing as it has successfully raised significant seed funding, which is a strong indicator of investor confidence and financial resources for expansion. The company secured …See details»
Kuano raises £1.8M in seed funding round to …
Cambridge, UK, 12 September 2023: Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by …See details»
Kuano - Funding, Financials, Valuation & Investors - Crunchbase
Kuano provides innovative quantum and AI solutions for drug discovery and design.See details»
Kuano: Revenue, Worth, Valuation & Competitors 2025
About Kuano Kuano is a Biotechnology Research related company based in London with 18 employees an estimated revenue of $1.8M, and. It has 10 competitors including Bitbrain, …See details»
Kuano 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Kuano. Use the PitchBook Platform to explore the full profile.See details»
Kuano Company Information - Funding, Investors, and More
Kuano, based in London, offers a quantum simulation platform aimed at transforming drug discovery for biotech and health tech companies. Their B2B, SaaS model provides faster and …See details»
Kuano - GitHub
Combining state-of-the-art simulation and AI to add quantum detail to structure based drug discovery. - KuanoSee details»
Kuano - Ascension
Kuano is providing innovative quantum and AI solutions for drug discovery and design. Their unique approach tackles common challenges in both AI driven drug design and target driven …See details»
Kuano uses OCI to create drug design platform to benefit ... - Oracle
Mar 7, 2024 Kuano is a biotechnology research startup based in the UK that aims to redefine drug discovery with quantum computing and AI. The organization wanted to develop a drug …See details»
Kuano.ai Company Profile - Office Locations, Competitors ... - Craft
Kuano.ai has 5 employees at their 1 location. See insights on Kuano.ai including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Kuano - EU-Startups
Our discovery platform uniquely combines target quantum mapping and AI led chemistry to enable faster development of better drug candidates. Our unique approach tackles common …See details»
Kuano closes £1.8M seed funding round to validate quantum …
Sep 13, 2023 Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding …See details»
Kuano Company Information - Funding, Investors, and More
Kuano An artificial intelligence company using quantum computing to create molecular design solutions.See details»
Kuano - Contacts, Employees, Board Members, Advisors & Alumni
Kuano provides innovative quantum and AI solutions for drug discovery and design.See details»
Our Approach — Kuano
Kuano's approach is to combine state-of-the-art simulation and AI to add quantum detail to structure based drug discovery. Our unique fusion of drug hunting and technology expertise …See details»
Building A High-Impact Data Engineering Team For Your AI …
6 hours ago If you’re founding or scaling an AI startup, don’t relegate data engineering to the background. Done right, it’s your unfair advantage.See details»
CDAOs might be key to genAI success now — but that could change
7 hours ago Chief Data & Analytics Officers are crucial to AI success, but by 2027, 75% of those who don't prove their value in AI leadership could lose their C-level role, Gartner warns.See details»
Kuano.ai Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Kuano.ai. See Kuano.ai company profile and funding data.See details»
OpenAI reverses course, says its nonprofit will remain in control of ...
May 5, 2025 OpenAI has decided that its nonprofit division will retain control over its for-profit org, after the company initially announced that it planned to convert to a for-profit organization.See details»